UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting the cell cycle in breast cancer: towards the next phase

Cell cycle (Georgetown, Tex.), 2018-08, Vol.17 (15), p.1871-1885

2018

Volltextzugriff (PDF)

Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2018-02, Vol.115 (7), p.E1570-E1577

2018

Volltextzugriff (PDF)

Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio

Cell death and differentiation, 2015-11, Vol.22 (11), p.1837-1845

2015

Volltextzugriff (PDF)

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Annals of oncology, 2019-03, Vol.30 (3), p.397-404

2019

Volltextzugriff (PDF)

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

Annals of oncology, 2019-03, Vol.30 (3), p.405-411

2019

Volltextzugriff (PDF)

PARP inhibitor sensitivity in BRCA-related metastatic breast cancer: an OlympiAD later

Annals of oncology, 2021-12, Vol.32 (12), p.1460-1462

2021

Volltextzugriff (PDF)

Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer

Annals of oncology, 2010-07, Vol.21 (7), p.1411-1418

2010

Volltextzugriff (PDF)

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

The New England journal of medicine, 2022-07, Vol.387 (3), p.217-226

2022

Volltextzugriff (PDF)

Abstract ES13-3: Novel epigenomic targets in TNBC

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.ES13-3-ES13-3

Cescon, DW

2022

Volltextzugriff (PDF)

p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma

Diseases of the esophagus, 2010-01, Vol.23 (1), p.36-39

2010

Volltextzugriff (PDF)

Characterizing mechanisms of resistance to BRAF and MEK inhibitors in cancers with Class 2 BRAF mutations: uncovering novel therapeutic opportunities

European journal of cancer (1990), 2022-10, Vol.174, p.S63-S64

2022

Volltextzugriff (PDF)

CCTG IND.231: A phase 1 trial evaluating CX-5461 in patients with advanced solid tumors

Annals of oncology, 2018-03, Vol.29, p.iii8-iii8

2018

Volltextzugriff (PDF)

44OCCTG IND.231: A phase 1 trial evaluating CX-5461 in patients with advanced solid tumors

Annals of oncology, 2018-03, Vol.29 (suppl_3)

2018

Volltextzugriff (PDF)

Bowel loops and eyelid droops

Canadian Medical Association journal, 2008-10, Vol.179 (9), p.927-929

2008

Volltextzugriff (PDF)

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area

JAMA : the journal of the American Medical Association, 2003-06, Vol.289 (21), p.2801

2003

Volltextzugriff (PDF)

Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning

Canadian Medical Association journal (CMAJ), 2009-01, Vol.180 (2), p.251-251

2009

Volltextzugriff (PDF)

Abstract P5-14-05: Capecitabine in early breast cancer: A meta-analysis of randomized controlled trials

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-14-05

2017

Volltextzugriff (PDF)

Abstract OT1-12-01: Exploration of factors associated with imminent risk of late recurrence in hormone receptor positive breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-12-01-OT1-12-01

2019

Volltextzugriff (PDF)

Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP super(+)/NADPH ratio

Cell death and differentiation, 2015-11, Vol.22 (11), p.1837-1845

2015

Volltextzugriff (PDF)

Barcoded medication administration: a last line of defense

JAMA : the journal of the American Medical Association, 2008-05, Vol.299 (18), p.2200

2008

Volltextzugriff (PDF)

Abstract P1-16-03: Phase II randomized clinical trial (RCT) of metformin (MET) vs placebo (PLAC) in combination with chemotherapy (CXT) in refractory locally advanced (LABC) or metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-16-03

2019

Volltextzugriff (PDF)

Abstract OT3-04-03: KEYNOTE-756: A randomized, double-blind, phase III study of pembrolizumab versus placebo in combination with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk early-stage ER+/HER2– breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT3-04-03-OT3-04-03

2019

Volltextzugriff (PDF)

Abstract P2-09-14: Association between BMI and residual estradiol levels in post-menopausal women using adjuvant letrozole: Results of a prospective study

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-09-14

2017

Volltextzugriff (PDF)

An analysis of vitamin D (Vit D) and serum estrogens in postmenopausal (PM) breast cancer (BC) patients receiving aromatase inhibitors (AIs)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.596-596

2011

Volltextzugriff (PDF)

Abstract P5-12-02: Effect of 5 vs 2.5 mg/day letrozole on residual estrogen levels in post-menopausal women with high BMI - A prospective crossover study

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P5-P5-12-02

2016

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(88)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(37)
Humans
(34)
Female
(27)
Middle Aged
(18)
Educational: Biology
(17)
Environmental Engineering & Technology
(17)
Adult
(15)
Antarctica
(15)
Male
(14)
Animals
(12)
Environmental Geology
(12)
Mice
(12)
Breast Cancer
(11)
Oncology
(11)
Pollution
(11)
Environmental Effects
(9)
Tumors
(9)
Aged
(8)
Cell Biology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeting the cell cycle in breast cancer: towards the next phase

Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer

Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

PARP inhibitor sensitivity in BRCA-related metastatic breast cancer: an OlympiAD later

Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

Abstract ES13-3: Novel epigenomic targets in TNBC

p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma

Characterizing mechanisms of resistance to BRAF and MEK inhibitors in cancers with Class 2 BRAF mutations: uncovering novel therapeutic opportunities

CCTG IND.231: A phase 1 trial evaluating CX-5461 in patients with advanced solid tumors

44OCCTG IND.231: A phase 1 trial evaluating CX-5461 in patients with advanced solid tumors

Bowel loops and eyelid droops

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area

Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning

Abstract P5-14-05: Capecitabine in early breast cancer: A meta-analysis of randomized controlled trials

Abstract OT1-12-01: Exploration of factors associated with imminent risk of late recurrence in hormone receptor positive breast cancer

Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP super(+)/NADPH ratio

Barcoded medication administration: a last line of defense

Abstract P1-16-03: Phase II randomized clinical trial (RCT) of metformin (MET) vs placebo (PLAC) in combination with chemotherapy (CXT) in refractory locally advanced (LABC) or metastatic breast cancer (MBC)

Abstract OT3-04-03: KEYNOTE-756: A randomized, double-blind, phase III study of pembrolizumab versus placebo in combination with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk early-stage ER+/HER2– breast cancer

Abstract P2-09-14: Association between BMI and residual estradiol levels in post-menopausal women using adjuvant letrozole: Results of a prospective study

An analysis of vitamin D (Vit D) and serum estrogens in postmenopausal (PM) breast cancer (BC) patients receiving aromatase inhibitors (AIs)

Abstract P5-12-02: Effect of 5 vs 2.5 mg/day letrozole on residual estrogen levels in post-menopausal women with high BMI - A prospective crossover study

Suchergebnisse filtern